您的位置：
首页
>
农业专利
>
详情页
Apoptosis signal-regulating kinase inhibitor
专利权人:
GILEAD SCIENCES INC.
发明人:
Notte Gregory
申请号：
NZ72294513
公开号：
NZ722945A
申请日:
2013.01.24
申请国别(地区):
NZ
年份:
2018
代理人:
摘要：
Disclosed is Selonsertib (5-(4-cyclopropyl-1H-imidazol-1-yl)-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-2-fluoro-4-methylbenzamide) and its use as an apoptosis signal-regulating kinase inhibitor for the treatment of kidney fibrosis, liver fibrosis, lung fibrosis, diabetic nephropathy or diabetic kidney disease.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
Apoptosis signal-regulating kinase inhibitor
A compound 5 - (4 - 2-cyclopropyl-1 - 1H imidazol-1-yl) - N - [6 - (4 - isopropyl - 4h-1,2,4-triazole - 3 - il) pyridin-2-yl) - 2 - fluoro 4-methylbenzamide or its Salts, such as regulating the Kinase Inhibitors apoptotic Signal； Intermediate Compounds, Pharmaceutical Composition and its use for the treatment of e Chronic renal epizootic, diabetic nephropathy, renal fibrosis, among others.
Tetrazole, 1,2,3-triazol, 1,2,4-triazol, 1,2,4-triazol, 1,2,4-oxadiazol, 1,3,4-oxadiazol and oxazol, from adenosine inhibitors； pharmacological synthesis and combination； cholesterol for the treatment of fibrosis, pruritus, cirrhosis, calcium, diabetes, kidney disease and pain.
Apoptosis signal-regulating kinase inhibitors
Triazol compounds for treating biofilm formation
